Web Stats Provided By Google Analytics

Tuesday, April 23, 2013

Theradiag Receives 3rd CE Mark Approval for New Anti-CCP In-Vitro...

Theradiag , a company specializing in theranostic and in vitro diagnostics, today announced it has obtained a CE mark for its proprietary anti-CCP in vitro diagnostic kit in rheumatoid arthritis.

http://www.businesswire.com/news/topix/20130422006250/en

No comments:

Post a Comment